摘要:
The present invention provides compounds of the formula: wherein R2 is substituted cycloalkyl, heterosubstituted cycloalkyl, heteroalkylsubstituted cycloalkyl, heterosubstituted cycloalkyl-alkyl, optionally substituted heterocyclyl, spiro-substituted cycloalkyl, aralkoxy, alkoxy, -alkylene-S(O)n-alkyl (wherein n is 1 or 2), or —SO2Ar2; and R1, R3, and Ar1 are those defined herein, and methods for preparation and uses thereof.
摘要翻译:本发明提供下式的化合物:其中R2是取代的环烷基,杂取代的环烷基,杂烷基取代的环烷基,杂取代的环烷基 - 烷基,任选取代的杂环基,螺取代的环烷基,芳烷氧基,烷氧基, - 亚烷基-S(O) 其中n为1或2)或-SO 2 Ar 2; 且R1,R3和Ar1是本文定义的那些,以及其制备方法和用途。
摘要:
The present invention provides compounds of the formula: wherein R1, R3, and Ar1 are those defined herein, and R2 is —CR′R″—Ra (where R′ and R″ are hydrogen, hydroxyalkyl or alkyl with at least one being alkyl or hydroxyalkyl and Ra is hydroxyalkyl), Rx—S—Ry— (where Rx is alkyl and Ry is alkylene), alkoxy-substituted alkyl, heterocyclylalkyl or C4-C5 cycloalkyl, wherein each of the hydroxy group present in R2 can be independently Ra—C(═O)—O, RaRbN—C(═O)—O, or Ra—S(O)2—O—, wherein Ra and Rb are independently hydrogen, alkyl, aryl, or aralkyl, and methods for preparation and uses thereof.
摘要翻译:本发明提供下式的化合物:其中R1,R3和Ar1是本文定义的,R2是-CR'R'-Ra(其中R'和R“是氢,羟基烷基或具有至少一个 (其中R x是烷基,R y是亚烷基),烷氧基取代的烷基,杂环基烷基或C 4 -C 5环烷基,其中R 2中存在的每个羟基可以是 独立地是R a -C(= O)-O,R a R b N-C(= O)-O或R a -S(O)2-O-,其中R a和R b独立地是氢,烷基,芳基或芳烷基, 用于其制备和使用。
摘要:
Disorders mediated by p38 kinase inhibitors are treated with compounds of the formula: or salts thereof, wherein: R1 is hydrogen or alkyl; R2 is substituted cycloalkyl, heterosubstituted cycloalkyl, helcroalkylsubstituted cycloalkyl, heterosubstituted cycloalkyl-alkly, heterocyclyl, heterocyclyl spiro cycloalkyl, aralkoxy, alkoxy, -alkylene-S(O)n-alkyl (where is 1 or 2) or —SO2Ar2; R3 is hydrogen, amino, monoalkylamino, dialkylamino, acylamino, —NR8—C(═O)—Rb (where Ra is hydrogen or alkyl and Rh is heterocyclyl or heteroalkyl), alkyl, cycloalkyl, phthalimidoalkyl, aryl, aralkyl, haloalkyl, heteroalkyl, cyanoalkyl, -alkylene-C(O) R (where R is hydrogen, alkyl, hydroxy, alkoxy, amino, monoalkylamino or dialkylamino) or acyl; and each of Ar1 and Ar2 is independently aryl.
摘要翻译:由p38激酶抑制剂介导的疾病用下式化合物或其盐处理,其中:R 1是氢或烷基; R 2是取代的环烷基,杂取代的环烷基,环烷基取代的环烷基,杂取代的环烷基 - 烷基,杂环基, 杂环基螺环烷基,芳烷氧基,烷氧基, - 亚烷基-S(O)n-烷基(其中为1或2)或-SO 2 Ar 2; R 3为氢,氨基,单烷基氨基,二烷基氨基,酰氨基, (其中R 1为氢或烷基且R h为杂环基或杂烷基),烷基,环烷基,苯二甲酰亚氨基烷基,芳基,芳烷基,卤代烷基,杂烷基,氰基烷基, - 亚烷基-C(O)R(其中R是氢,烷基,羟基,烷氧基,氨基,单烷基氨基或二烷基氨基)或酰基; Ar 1和Ar 2的每一个独立地是芳基。
摘要:
The present invention provides compounds of the formula: a prodrug or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3 and Ar1 are those defined herein, and methods for preparation and uses thereof.
摘要:
The present invention provides compounds of the Formula I and II: wherein R1, R3, W, Z, X1, X2, Ar1, R8 and R9 are as defined herein, and methods and intermediates for their preparation and uses thereof.
摘要:
The present invention provides compounds of the Formula I and II: wherein R1, R3, W, Z, X1, X2, Ar1, R8 and R9 are as defined herein, and methods and intermediates for their preparation and uses thereof.
摘要:
The present invention provides compounds of the Formula I and II: wherein R1, R3, W, Z, X1, X2, Ar1, R8 and R9 are as defined herein, and methods and intermediates for their preparation and uses thereof.
摘要:
The present invention provides compounds of the Formula I: wherein R1 is alkyl, cycloalkyl, cycloalkylalkyl, or —CH2-alkenyl, X1 is O, NH, N(alkyl), S or —C(═O), Z is N or CH; and R2 and R3 are as defined herein, pharmaceutical compositions comprising same, and methods for their use.
摘要翻译:本发明提供了式I的化合物:其中R 1是烷基,环烷基,环烷基烷基或-CH 2 - 烯基,X 1, 是O,NH,N(烷基),S或-C(-O),Z是N或CH; R 2和R 3如本文所定义,包含其的药物组合物及其使用方法。
摘要:
The present invention provides compounds of the Formula I: wherein R1 is alkyl, cycloalkyl, cycloalkylalkyl, or —CH2-alkenyl, X1 is O, NH, N(alkyl), S or —C(═O), Z is N or CH; and R2 and R3 are as defined herein, pharmaceutical compositions comprising same, and methods for their use.
摘要翻译:本发明提供了式I的化合物:其中R 1是烷基,环烷基,环烷基烷基或-CH 2 - 烯基,X 1, 是O,NH,N(烷基),S或-C(-O),Z是N或CH; R 2和R 3如本文所定义,包含其的药物组合物及其使用方法。
摘要:
The present invention provides compounds of the Formula I: wherein R1 is alkyl, cycloalkyl, cycloallkylalkyl, or —CH2-alkenyl, X1 is O, NH, N(alkyl), S or —C(═O), Z is N or CH; and R2 and R3 are as defined herein, pharmaceutical compositions comprising same, and methods for their use.